Submission declined on 31 January 2025 by Dan arndt (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Once you save your changes using the "Publish changes" button below, you will be able to resubmit your draft for review by pressing the "Resubmit" button that will appear here. |
Anitah Ghansah is a Ghanaian genetic epidemiologist. She is currently as Associate Professor[1] at the Noguchi Memorial Institute for Medical Research at the University of Ghana.[2] She is a pioneer in bioinformatics training within Ghana and has introduced expertise for genotyping molecular markers of drug resistance[3]. These efforts led to ground breaking policy changes in Ghana's approach to malaria treatment from chloroquine to artemisinin-based combination therapies.
In November 2021, Ghansah was selected as a Calestous Juma Science Leadership Fellow by the Bill and Melinda Gates Foundation to spearhead the development of a cost-efficient malaria molecular surveillance system in Ghana.[4] She will rapidly monitor key molecular markers of drug and diagnostic resistance in blood samples from malaria patients using high-throughput sequencing and bioinformatics.
{{cite journal}}
: CS1 maint: PMC format (link)